CTRI/2023/03/050199尚未招募未知
A Randomized double-blind placebo-controlled clinical trial to evaluate the safety and efficacy of hair vitamin gummies in reducing hair fall and improving hair and nail health in adults - NI
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female subjects in general good health;
- •2.Subjects in the age group of 18-35 years (both inclusive);
- •3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit;
- •4. Female subjects falling under Grade roman number one-1 to roman number two-1 of Savins pictorial grading of female pattern hair loss or male subjects falling under Grade two to four A of hair loss severity grade evaluated as per Norwood scale;
- •5.Subject with at least one of the following complaints-
- •Dry damaged hair
- •Brittle and thin hair
- •Hair loss evident while combing or after washing
- •Perceived reduced hair density
- •Scalp related complaints like itching, dandruff or irritation.
排除标准
- •1.Subjects who are undergoing hair growth treatment within 3 months before screening into the study;
- •2.Subjects having any active scalp disease which may interfere in the study;
- •3.Subjects on treatment for active acne;
- •4.Subjects with history or active phase of malignancy and chemotherapy;
- •5.Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania;
- •6.Subjects who have had hair transplant;
- •7.Subjects who take pharmaceutical product which cause hirsutism;
- •8.Subjects on oral hair growth medications which will compromise the study;
- •9.Chronic illness which may influence the study;
- •10.Subjects participating in other similar cosmetic or therapeutic trial within last two weeks;
- •11.Pregnant or lactating mothers;
- •12.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension (â?º140/90 mmHg), HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness;
- •13.Any other condition, as per the discretion of the investigator, that can impact the study outcome or subjects will not be considered in the study.
研究者
相似试验
招募中
3 期
A study in subjects with Symptomatic genetic heart disease comparing sponsors drug Mavacamten with dummy drug.CTRI/2023/10/058870MyoKardia, Inc.
已完成
不适用
A clinical trial to evaluate efficacy and safety of the study drug Neuroroj in treatment of painful Peripheral Diabetic Neuropathy (PDN)CTRI/2019/04/018678BigBrother Nutra Care Pvt Ltd50
招募中
3 期
Antibtiotics for Asymptomatic Acute Otitis MediaAcute otitis media without perforationEar - Other ear disordersACTRN12608000424303Menzies School of Health Research300
进行中(未招募)
1 期
Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 weeks in Newly Diagnosed Children and Adolescents Outpatients with Attention-Deficit/Hyperactivity DisorderEUCTR2004-004088-31-ESilly S.A.151
进行中(未招募)
1 期
A research study investigating semaglutide in people with early Alzheimer's disease (EVOKE)Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer's type.MedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2020-004848-29-ITOVO NORDISK. S.P.A.1,840
